MDNews - Eastern Pennsylvania/Northwest New Jersey

May/June 2014

Issue link: https://viewer.e-digitaledition.com/i/321198

Contents of this Issue

Navigation

Page 7 of 15

Improving on Colon Cancer Prevention Despite what studies have suggested, colonoscopy screening remains the best approach to preventing colon cancer. Guidelines are not an absolute, and endoscopists should consider the patient's family history, genetic circumstances, age and other factors when determining screening frequency. The physicians at Lehigh Valley Colon and Rectal Specialists err on the side of caution when it comes to protecting their patients, Dr. Stasik says. "Colonoscopy involves a 20 percent error rate," he adds. "As our knowledge changes, we have to make corresponding changes in our patient care." Good endoscopy technique results in good outcomes. A 2014 study by Kaiser Permanente found that a physician's rate of polyp detection showed a positive asso- ciation with his or her patients' risk of dying from colon cancer. For this reason, the phy- sicians at Lehigh Valley Colon and Rectal Specialists audit their results, consistently finding adenomatous polyps in about 30 percent of their screening colonoscopies. "We follow many of the recommenda- tions of other experts in the field, and there are two ways we are improving our colonoscopic screening: first, by our choice of bowel-cleansing preparations, and second, by strict colonoscopy auditing," Dr. Bub says. "We improve our colonoscopy technique by utilizing a split bowel prepa- ration for colon cleansing. Historically, we gave patients a gallon of salty liquid to drink the day before the procedure. They would comply, but the night before the procedure, after they had taken the last dose, their bodies would produce bilious liquid that coats the right side of the colon, the specific area the endoscopist needs to see well. Now, patients take a split dose — half at 5 p.m. the day before their colonoscopy, followed by a second dose about four hours before the procedure. Colon cleansing is significantly improved, allowing for increased polyp detection." Rigorous auditing of colonoscopy findings and polyp removal is another way physicians at Lehigh Valley Colon and Rectal Specialists ensure thoroughness. Auditing is a proven method of demonstrat- ing sound endoscopy techniques. Lehigh Valley's auditing program includes metrics such as the endoscopist's adenoma detection rate, their percent- age of adenomas detected on screening colonoscopy. The adenoma detection rate by Drs. Bub and Stasik are consistently above national averages of 15 percent for women and 25 percent for men. The adenoma detection rate per procedure, the percentage of serrated polyps found and the rate of interval colon cancers — those found within five years of a screening colonoscopy — may also soon be included as audit measures, Dr. Bub says. Screening for Anal Cancer Lehigh Va lley Colon a nd Recta l Specialists offers other services that enhance its value to referring physicians, as well. Among these, high-resolution anoscopy allows physicians to detect anal cancers in high-risk patients. "Men and women who have HIV, specifically men who have sex with men, and women who have been diag- nosed with cervical dysplasia should be screened for anal cancer," Dr. Bub says. "This screening involves an anal Pap smear. If the patient has atypical cells, we can perform high-resolution anoscopy [HR A] to identify and treat anal dysplasia. We are the only practice in Allentown offering HRA." Whatever patients' and referring pro- viders' concerns, they will be met with careful attention at Lehigh Valley Colon and Rectal Specialists. "We work hard to remain relevant to our partners," Dr. Bub says. "While following all the appropriate recommendations, we are also performing research to help define screening guidelines for the future." To refer a patient to Lehigh Valley Colon and R ectal Speciali st s, vi sit w w w. a l l e n t o w n c o l o n r e c t a l .c o m o r call 610- 433-7571. ■ COV ER FE AT UR E M EE T T H E P H YS I C I A N S David S. Bub, MD, FACS, FASCRS Assistant Clinical Professor, Temple University School of Medicine Medical school: New York University School of Medicine Residency: St. Luke's–Roosevelt Hospital Center Fellowship: Greater Baltimore Medical Center Research interests: diagnosis, staging and management of rectal cancer; molecular markers in colon cancer Consumer publication: 100 Questions & Answers about Colorectal Cancer John J. Stasik, MD, FACS, FASCRS Medical school: Hahnemann School of Medicine Residency: Allentown General Hospital Fellowship: Sacred Heart Hospital Research interests: colon and rectal surgery; recurrent colorectal cancer; colonoscopy efficacy and guidelines 8 | Eastern Pennsylvania/NW New Jersey MD NEWS ■ M D N E W S . CO M

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Eastern Pennsylvania/Northwest New Jersey - May/June 2014